6th Nordic Pharmacovigilance Conference 2019

In cooperation with the Nordic national competent authorities and the Nordic pharma industry.

Who should attend?

Professionals who have an interest in pharmacovigilance and drug safety with an EU/Nordic focus will benefit from attending the conference. We welcome participants from pharmaceutical companies (HQ and affiliates), pharmaceutical industry associations, national competent authorities, contract research organisations and consultants. You may also be working in the field of regulatory affairs, drug discovery/drug development or drug information and marketing.

Program

Preliminary program is available here.

Participation fee

Early registration (until February 24, 2019) SEK 4 000 exclusive VAT. Late registration (from February 25, 2019) SEK 5 000 exclusive VAT. The participation fee includes lunch and coffee.

Exhibition

During the 6th Nordic Pharmacovigilance Conference we offer an exhibition package at a price of SEK 11 500 exclusive VAT. All stands are equipped with a bar table and a place for the exhibitor’s roll up. The fee also includes a complimentary registration for one company representative, including lunch and coffee for the conference day.

Time and Venue

The conference starts at 09:00 hrs with registration from 08:30 hrs and ends at approximately 17.00 hrs.
Felix Conference Center in Oslo.

Accommodation

We recommend the following hotels:

Thon Hotel Vika Atrium (the closest hotel to the conference venue)

Scandic Hotel Parkveien 68, NO-2458, Oslo, Norway.  To book a room please contact solli@scandichotels.com (10 min walk from the venue)

Thon Hotels, Thon Hotel Cecil and Thon Hotel Europa.

Program Committee

Mia Bengtström, PIF, Annemette Boye, Merck, Jacob Gardarsson, Frumtök, Elsa Hedén, Bayer, Inge Johansson, LMI, Maija Kaukonen, FIMEA, Minna Lindholm, MSD Finland, Marie Lundström, Swedish Medical Products Agency, Linda Melkersson, LIF, Morten Mevaag, Roche, Sari Peltonen, Pfizer, Jukka Pesonen, Orion, Mikkel Rasmussen, LIF, Birgitte Scharling, Novo Nordisk and Margrethe Sorgaard, Norwegian Medicines Agency.

Participant list and Personal data

We usually share a list of participants during our conferences. Many participants request these lists and we see networking as an important part of the professional development. With reference to this, we assume that our participants have an interest in us sharing the list and the lawfulness of processing the personal data is therefore the legitimate interest. The lists contain first and last name and organization. If you do not want your name and organization to be included in the participant list, please notify the project administrator at the time of registration or else as soon as possible. If you have questions regarding the participant list, you are welcome to contact the responsible project administrator.

When you sign up for 6th Nordic Pharmacovigilance Conference, an agreement is concluded between you and Legemiddelindustrien (LMI), which means that LMI will process your personal data in order to fulfill its part of the agreement and conduct the conference in a satisfactory manner. LMI organizes the conference with the assistance of Läkemedelsakademin i Stockholm AB (LMA), which means that LMA will process your contact information and other personal data on behalf of LMI to the extent necessary to administer the conference.
By signing up for the conference, you also agree that LMA will independently register your contact information in order to inform you about upcoming conferences of the same kind as well as other opportunities for skills development that LMA believe may be of interest to you. If you do not wish to receive such information from LMA in the future, please contact us at info@lakemedelsakademin.se

Link to LMA privacy policy